Cargando…

Opt‐in for secondary findings as part of diagnostic whole‐exome sequencing: Real‐life experience from an international diagnostic laboratory

BACKGROUND: Discussion about the risks and benefits of offering secondary findings as part of genome‐wide diagnostics lacks real‐life data. We studied the opt‐in decisions of patients/families referred to whole exome study (WES) in Blueprint Genetics (BpG), a genetic testing company with customers i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunfeldt, Minna, Kaare, Milja, Saarinen, Inka, Koskenvuo, Juha, Kääriäinen, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422066/ https://www.ncbi.nlm.nih.gov/pubmed/37025058 http://dx.doi.org/10.1002/mgg3.2180

Ejemplares similares

Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders
por: Trotta, Luca, et al.
Publicado: (2018)

Simulating the Genetics Clinic of the Future — whether undergoing whole-genome sequencing shapes professional attitudes
por: Brunfeldt, Minna, et al.
Publicado: (2022)

Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis
por: Gall, Kimberly, et al.
Publicado: (2021)

Diagnostic value of exome and whole genome sequencing in craniosynostosis
por: Miller, Kerry A, et al.
Publicado: (2017)

Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
por: Scocchia, Alicia, et al.
Publicado: (2021)

Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients
por: Cousin, Margot A., et al.
Publicado: (2017)

Correction to: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
por: Scocchia, Alicia, et al.
Publicado: (2022)

Whole-exome sequencing in neurologic practice: Reducing the diagnostic odyssey
por: Johnson, Nicholas E.
Publicado: (2015)

Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy
por: Long, Pamela A., et al.
Publicado: (2017)

Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy
por: Walsh, Maie, et al.
Publicado: (2017)

Molecular Diagnostic Experience of Whole-Exome Sequencing in Adult Patients
por: Posey, Jennifer E., et al.
Publicado: (2015)

Diagnostic Challenges of Neuromuscular Disorders after Whole Exome Sequencing
por: Chen, Pin-Shiuan, et al.
Publicado: (2023)

Application of Prenatal Whole Exome Sequencing for Structural Congenital Anomalies—Experience from a Local Prenatal Diagnostic Laboratory
por: Lai, Theodora Hei Tung, et al.
Publicado: (2022)

Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients
por: Heliö, Krista, et al.
Publicado: (2023)

Secondary findings in 421 whole exome-sequenced Chinese children
por: Chen, Wen, et al.
Publicado: (2018)

Whole exome sequencing as a diagnostic tool for patients with ciliopathy-like phenotypes
por: Castro-Sánchez, Sheila, et al.
Publicado: (2017)

Diagnostic value of whole‐exome sequencing in Chinese pediatric‐onset neuromuscular patients
por: Tsang, Mandy H. Y., et al.
Publicado: (2020)

Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel
por: Tal-Ben Ishay, Rotem, et al.
Publicado: (2021)

Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients
por: Hathaway, Julie, et al.
Publicado: (2021)

Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy
por: Mak, Timothy Shin Heng, et al.
Publicado: (2018)

Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach
por: Córdoba, Marta, et al.
Publicado: (2018)

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics
por: van der Lee, Maaike, et al.
Publicado: (2019)

The potential diagnostic yield of whole exome sequencing in pregnancies complicated by fetal ultrasound anomalies
por: Diderich, Karin E. M., et al.
Publicado: (2020)

Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis
por: Ewans, Lisa J., et al.
Publicado: (2022)

Diagnostic yield of chromosomal microarray and trio whole exome sequencing in congenital brain anomalies
por: Fonova, E. A., et al.
Publicado: (2023)

Consent in escrow: opting to opt in
por: Van der Loos, Kiah I., et al.
Publicado: (2015)

Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing
por: Shahmirzadi, Layla, et al.
Publicado: (2014)

Assessing the necessity of confirmatory testing for exome sequencing results in a clinical molecular diagnostic laboratory
por: Strom, Samuel P., et al.
Publicado: (2014)

An Initial Survey of the Performances of Exome Variant Analysis and Clinical Reporting Among Diagnostic Laboratories in China
por: Zhang, Kuo, et al.
Publicado: (2020)

Evaluation of Diagnostic Yield in Fetal Whole-Exome Sequencing: A Report on 45 Consecutive Families
por: Greenbaum, Lior, et al.
Publicado: (2019)

Whole Exome Sequencing as a Diagnostic Tool for Unidentified Muscular Dystrophy in a Vietnamese Family
por: Nguyen, Ngoc-Lan, et al.
Publicado: (2020)

Molecular diagnostic in fetuses with isolated congenital anomalies of the kidney and urinary tract by whole‐exome sequencing
por: Zhou, Xiaoyan, et al.
Publicado: (2020)

Deep phenotyping and whole‐exome sequencing improved the diagnostic yield for nuclear pedigrees with neurodevelopmental disorders
por: Wang, Qingqing, et al.
Publicado: (2022)

Not Only Diagnostic Yield: Whole-Exome Sequencing in Infantile Cardiomyopathies Impacts on Clinical and Family Management
por: Pezzoli, Laura, et al.
Publicado: (2021)

Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis
por: Skarp, Sini, et al.
Publicado: (2018)

Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases
por: Salfati, Elias L., et al.
Publicado: (2019)

A homozygous mutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey
por: Bacino, Carlos A., et al.
Publicado: (2015)

Utility of whole‐exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care
por: Sawyer, S.L., et al.
Publicado: (2015)

Rapid Whole-Exome Sequencing as a Diagnostic Tool in a Neonatal/Pediatric Intensive Care Unit
por: Śmigiel, Robert, et al.
Publicado: (2020)

The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing
por: Wang, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9pb62rr9lte4m61cftqri4f9de